The Evolution® Biliary Stent System-Fully Covered study is a clinical trial approved by the US FDA to evaluate the effectiveness of the Evolution® Biliary Stent System-Fully Covered when used in palliation of malignant neoplasms in the biliary tree.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
90
Implantation of the Evolution® Biliary Stent-Fully Covered in the common bile duct utilizing ERCP
University of Colorado Hospital
Aurora, Colorado, United States
Borland-Groover Clinic
Jacksonville, Florida, United States
Moffitt Cancer Center
Tampa, Florida, United States
Percentage of patients free from symptomatic recurrent of biliary obstruction requiring reintervention
Time frame: 6 months
Total Serum Bilirubin ≤ 3.0 mg/dL
Time frame: 1 month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Indiana University Hospital
Indianapolis, Indiana, United States
Wake Forest Baptist Medical Center
Winston-Salem, North Carolina, United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
University of Virginia Health System
Charlottesville, Virginia, United States
St. Michael's Hospital
Toronto, Ontario, Canada
Centre Hospitalier de 1'Université
Montreal, Quebec, Canada
Hôpital Edouard Herriot
Lyon, France
...and 2 more locations